{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:48:40Z","timestamp":1787240920635,"version":"build-2736575974"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T00:00:00Z","timestamp":1626048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004572","name":"National Health and Family Planning Commission of the People's Republic of China","doi-asserted-by":"publisher","award":["201402005"],"award-info":[{"award-number":["201402005"]}],"id":[{"id":"10.13039\/501100004572","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bilateral lesions are common in papillary thyroid carcinoma (PTC). For patients with unilateral PTC, occult carcinoma that is not detected preoperatively, but pathologically after surgery, might remain in the contralateral lobe. In this situation, inadequate surgical extent could cause relapse and even lead to re-operation. Here, we explore the frequency and investigate the risk factors of contralateral occult PTC in unilateral PTC through a retrospective study conducted by our team and published articles online, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We collected the patients\u2019 clinical data in our hospital, whose cancer was determined to be confined to the unilateral lobe by preoperative image examination (N = 204). These patients underwent initially total or near-total thyroidectomy and included their clinical data in the meta-analysis. We searched related literature in the PubMed, Embase, MEDLINE, Cochrane, and Web of Science databases until December 7, 2020, in order to perform a meta-analysis. The relevant articles were examined and the eligible studies were included to assess the association between clinicopathologic factors and contralateral occult PTC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The meta-analysis included nine studies (involving 4347 patients). Of these, eight studies were from the databases, and one study was our retrospective data. The meta-analysis showed that the prevalence of contralateral occult PTC was 26.6% in all patients. A tumor size &amp;gt; 1\u00a0cm, ipsilateral multifocality, contralateral benign nodule, and central lymph node metastasis were significantly associated with contralateral occult PTC. In contrast, sex, age, ETE, capsular invasion,\n                      <jats:italic>BRAF<\/jats:italic>\n                      mutation, Hashimoto thyroiditis, and lateral lymph node metastasis were insignificantly associated with contralateral occult PTC.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The meta-analysis identified a tumor size &amp;gt; 1\u00a0cm, ipsilateral multifocality, contralateral benign nodule, and CLNM as being significant risk factors for contralateral occult PTC. These findings may guide the extent of surgery in unilateral PTC patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2021.675643","type":"journal-article","created":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T00:35:10Z","timestamp":1626050110000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Risk Factors for Contralateral Occult Carcinoma in Patients With Unilateral Papillary Thyroid Carcinoma: A Retrospective Study and Meta-Analysis"],"prefix":"10.3389","volume":"12","author":[{"given":"Fan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xichang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer Statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.18528","article-title":"Changes in Trends in Thyroid Cancer Incidence in the United States, 1992 to 2016","volume":"322","author":"Powers","year":"2019","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-014-3846-8","article-title":"Total Thyroidectomy Is Associated With Increased Risk of Complications for Low- and High-Volume Surgeons","volume":"21","author":"Hauch","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.4457","article-title":"Population-Based Study Evaluating and Predicting the Probability of Death Resulting From Thyroid Cancer and Other Causes Among Patients With Thyroid Cancer","volume":"31","author":"Yang","year":"2013","journal-title":"J Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.2719","article-title":"Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013","volume":"317","author":"Lim","year":"2017","journal-title":"JAMA"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2016.3094","article-title":"Diagnostic Value of Contrast-Enhanced Ultrasound in Papillary Thyroid Microcarcinoma","volume":"11","author":"Chen","year":"2016","journal-title":"Exp Ther Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"809382","DOI":"10.1155\/2013\/809382","article-title":"Prognosis of Multifocal Papillary Thyroid Carcinoma","volume":"2013","author":"Kuo","year":"2013","journal-title":"Int J Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"4208178","DOI":"10.1155\/2017\/4208178","article-title":"Therapeutic Outcomes of Patients With Multifocal Papillary Thyroid Microcarcinomas and Larger Tumors","volume":"2017","author":"Ng","year":"2017","journal-title":"Int J Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3342\/ceo.2015.8.2.174","article-title":"Multifocality and Bilaterality of Papillary Thyroid Microcarcinoma","volume":"8","author":"So","year":"2015","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for Adult Patients With Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2020.01.023","article-title":"Predictive Factors for Occult Bilateral Papillary Thyroid Carcinoma","volume":"28","author":"Wang","year":"2021","journal-title":"Acad Radiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.21037\/gs-19-157","article-title":"Predictive Factors of Contralateral Occult Carcinoma in Patients With Papillary Thyroid Carcinoma: A Retrospective Study","volume":"9","author":"Chen","year":"2020","journal-title":"Gland Surg"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.7314\/APJCP.2015.16.7.2947","article-title":"The BRAFT1799A Mutation Is Not Associated With Occult Contralateral Carcinoma in Patients With Unilateral Papillary Thyroid Microcarcinoma","volume":"16","author":"Wan","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"B14","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement","volume":"3","author":"Moher","year":"2009","journal-title":"Open Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical Evaluation of the Newcastle-Ottawa Scale for the Assessment of the Quality of Nonrandomized Studies in Meta-Analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.553577","article-title":"Management of Clinically Solitary Papillary Thyroid Carcinoma Patients According to Risk-Scoring Model for Contralateral Occult Carcinoma","volume":"11","author":"Feng","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0315","article-title":"Multifocality of the Primary Tumor Is a Predictive Factor for Contralateral Occult Carcinoma in Patients With Unilateral Papillary Thyroid Carcinoma","volume":"9","author":"Gu","year":"2016","journal-title":"Int J Clin Exp Patho"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-009-0906-6","article-title":"Occult Contralateral Carcinoma in Patients With Unilateral Papillary Thyroid Microcarcinoma","volume":"17","author":"Koo","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13506","article-title":"Risk Factors Stratifying Malignancy of Nodules in Contralateral Thyroid Lobe in Patients With Pre-Operative Ultrasound Indicated Unilateral Papillary Thyroid Carcinoma: A Retrospective Analysis From Single Centre","volume":"88","author":"Lv","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.7314\/APJCP.2012.13.4.1267","article-title":"Preoperative BRAF Mutation Is Predictive of Occult Contralateral Carcinoma in Patients With Unilateral Papillary Thyroid Microcarcinoma","volume":"13","author":"Zhou","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-008-4027-9","article-title":"Complications in Primary and Completed Thyroidectomy","volume":"40","author":"Vaiman","year":"2010","journal-title":"Surg Today"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2012.08.053","article-title":"Prospective Evaluation of Total Thyroidectomy Versus Ipsilateral Versus Bilateral Central Neck Dissection in Patients With Clinically Node-Negative Papillary Thyroid Carcinoma","volume":"152","author":"Raffaelli","year":"2012","journal-title":"Surgery"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2011.02.004","article-title":"Prophylactic Central Lymph Node Dissection for Clinically Node-Negative Papillary Thyroid Microcarcinoma: Influence on Serum Thyroglobulin Level, Recurrence Rate, and Postoperative Complications","volume":"151","author":"So","year":"2012","journal-title":"Surgery"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29123","article-title":"Should Small Papillary Thyroid Cancer be Observed? A population-based study","volume":"121","author":"Nilubol","year":"2015","journal-title":"Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"11412","DOI":"10.1038\/s41598-017-11788-8","article-title":"Reevaluating the Prognostic Significance of Male Gender for Papillary Thyroid Carcinoma and Microcarcinoma: A SEER Database Analysis","volume":"7","author":"Liu","year":"2017","journal-title":"Sci Rep"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2008-0194","article-title":"Understanding the Relationship Between Age and Thyroid Cancer","volume":"14","author":"Haymart","year":"2009","journal-title":"Oncologist"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0315","article-title":"An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC\/UICC Staging System for Well-Differentiated Thyroid Cancer","volume":"26","author":"Nixon","year":"2016","journal-title":"Thyroid"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-013-1913-0","article-title":"How Many Contralateral Papillary Thyroid Carcinomas can be Missed","volume":"37","author":"Lee","year":"2013","journal-title":"World J Surg"},{"key":"B29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1477-7819-10-67","article-title":"Factors Predictive of Papillary Thyroid Micro-Carcinoma With Bilateral Involvement and Central Lymph Node Metastasis: A Retrospective Study","volume":"10","author":"Zhou","year":"2012","journal-title":"World J Surg Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2008.09.011","article-title":"Contralateral Papillary Thyroid Cancer: Does Size Matter","volume":"197","author":"Pitt","year":"2009","journal-title":"Am J Surg"},{"key":"B31","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.surg.2008.08.035","article-title":"Papillary Thyroid Microcarcinoma: A Study of 900 Cases Observed in a 60-Year Period","volume":"144","author":"Hay","year":"2008","journal-title":"Surgery"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1546","article-title":"Risk Factors for Neck Nodal Metastasis in Papillary Thyroid Microcarcinoma: A Study of 1066 Patients","volume":"97","author":"Zhang","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-016-0955-0","article-title":"Association of Multifocality, Tumor Number, and Total Tumor Diameter With Clinicopathological Features in Papillary Thyroid Cancer","volume":"53","author":"Tam","year":"2016","journal-title":"Endocrine"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2017.12.035","article-title":"Multifocality as a Prognostic Factor in Thyroid Cancer: A Meta-Analysis","volume":"50","author":"Joseph","year":"2018","journal-title":"Int J Surg"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1067\/mhn.2001.113141","article-title":"Extrathyroid Spread in Papillary Carcinoma of the Thyroid: Clinicopathological and Prognostic Study","volume":"124","author":"Ortiz","year":"2001","journal-title":"Otolaryngol Head Neck Surg"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2015.05.010","article-title":"Characteristics and Significance of Minimal and Maximal Extrathyroidal Extension in Papillary Thyroid Carcinoma","volume":"51","author":"Jin","year":"2015","journal-title":"Oral Oncol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2020.06.015","article-title":"Significance of Multifocality in Papillary Thyroid Carcinoma","volume":"46","author":"Feng","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0628","article-title":"American Thyroid Association Guidelines on the Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and Recommendation on the Proposed Renaming of Encapsulated Follicular Variant Papillary Thyroid Carcinoma Without Invasion to Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features","volume":"27","author":"Haugen","year":"2017","journal-title":"Thyroid"},{"key":"B39","article-title":"Risk Factors for Predicting Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma (CN0): A Study of 273 Resections","volume":"21","author":"Li","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-4486.2010.02085.x","article-title":"Treatment and Prognostic Factors of Papillary Thyroid Microcarcinoma","volume":"35","author":"Giordano","year":"2010","journal-title":"Clin Otolaryngol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1159\/000443032","article-title":"Meta-Analyses of Association Between BRAF(V600E) Mutation and Clinicopathological Features of Papillary Thyroid Carcinoma","volume":"38","author":"Zhang","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1530\/EC-19-0246","article-title":"Relationship Between BRAF V600E and Clinical Features in Papillary Thyroid Carcinoma","volume":"8","author":"Yan","year":"2019","journal-title":"Endocr Connect"},{"key":"B43","doi-asserted-by":"publisher","first-page":"393","DOI":"10.14639\/0392-100X-1709","article-title":"Clinical Analysis of Hashimoto Thyroiditis Coexistent With Papillary Thyroid Cancer in 1392 Patients","volume":"37","author":"Liang","year":"2017","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0130","article-title":"Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis","volume":"25","author":"Al Afif","year":"2015","journal-title":"Thyroid"},{"key":"B45","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12957-018-1336-3","article-title":"Risk Factors of Lateral Lymph Node Metastasis in cN0 Papillary Thyroid Carcinoma","volume":"16","author":"Hu","year":"2018","journal-title":"World J Surg Oncol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.675643\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T00:35:13Z","timestamp":1626050113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.675643\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,12]]},"references-count":45,"alternative-id":["10.3389\/fendo.2021.675643"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.675643","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,12]]},"article-number":"675643"}}